Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Energy Balance Modulation Impacts Epigenetic Reprogramming, ERα and ERβ Expression, and Mammary Tumor Development in MMTV-neu Transgenic Mice.

Rossi EL, Dunlap SM, Bowers LW, Khatib SA, Doerstling SS, Smith LA, Ford NA, Holley D, Brown PH, Estecio MR, Kusewitt DF, deGraffenried LA, Bultman SJ, Hursting SD.

Cancer Res. 2017 May 1;77(9):2500-2511. doi: 10.1158/0008-5472.CAN-16-2795. Epub 2017 Apr 3.

2.

Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway.

Bowers LW, Wiese M, Brenner AJ, Rossi EL, Tekmal RR, Hursting SD, deGraffenried LA.

PLoS One. 2015 Dec 28;10(12):e0145452. doi: 10.1371/journal.pone.0145452. eCollection 2015.

3.

Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.

Wong AW, Dunlap SM, Holcomb VB, Nunez NP.

Alcohol Clin Exp Res. 2012 Apr;36(4):577-87. doi: 10.1111/j.1530-0277.2011.01654.x. Epub 2011 Oct 7.

PMID:
21981381
4.

HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis.

Tekmal RR, Nair HB, Perla RP, Kirma N.

J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):111-8. Epub 2007 May 24.

5.

PES1 promotes breast cancer by differentially regulating ERα and ERβ.

Cheng L, Li J, Han Y, Lin J, Niu C, Zhou Z, Yuan B, Huang K, Li J, Jiang K, Zhang H, Ding L, Xu X, Ye Q.

J Clin Invest. 2012 Aug;122(8):2857-70. doi: 10.1172/JCI62676. Epub 2012 Jul 23.

6.

Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity.

Nogueira LM, Dunlap SM, Ford NA, Hursting SD.

Endocr Relat Cancer. 2012 Feb 13;19(1):57-68. doi: 10.1530/ERC-11-0213. Print 2012 Feb.

PMID:
22143497
7.

DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.

Brandão YO, Toledo MB, Chequin A, Cristo TG, Sousa RS, Ramos EAS, Klassen G.

Vet Pathol. 2018 Jul;55(4):510-516. doi: 10.1177/0300985818763711. Epub 2018 Mar 22.

PMID:
29566609
8.

Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues.

Ma Z, Parris AB, Howard EW, Shi Y, Yang S, Jiang Y, Kong L, Yang X.

Carcinogenesis. 2018 Oct 8;39(10):1264-1273. doi: 10.1093/carcin/bgy096.

PMID:
30107476
9.

Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India.

Chattopadhyay S, Deo SV, Shukla NK, Husain SA.

Tumour Biol. 2014 Aug;35(8):7911-9. doi: 10.1007/s13277-014-2052-4. Epub 2014 May 16.

PMID:
24833090
10.

Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?

Daraei A, Izadi P, Khorasani G, Nafissi N, Naghizadeh MM, Younosi N, Meysamie A, Mansoori Y, Bastami M, Tavakkoly-Bazzaz J.

Genet Test Mol Biomarkers. 2017 Aug;21(8):464-470. doi: 10.1089/gtmb.2017.0028. Epub 2017 Jul 14.

PMID:
28708432
11.

Estrogen receptor-beta mediates the protective effects of aromatase induction in the MMTV-Her-2/neu x aromatase double transgenic mice.

Nair HB, Perla RP, Kirma NB, Krishnegowda NK, Ganapathy M, Rajhans R, Nair SS, Saikumar P, Vadlamudi RK, Tekmal RR.

Horm Cancer. 2012 Apr;3(1-2):26-36. doi: 10.1007/s12672-011-0083-5.

PMID:
22006184
12.

Obesity, independent of p53 gene dosage, promotes mammary tumor progression and upregulates the p53 regulator microRNA-504.

Ford NA, Dunlap SM, Wheatley KE, Hursting SD.

PLoS One. 2013 Jun 28;8(6):e68089. doi: 10.1371/journal.pone.0068089. Print 2013.

13.

Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.

Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.

Int J Oncol. 2005 Aug;27(2):327-35.

PMID:
16010412
14.

Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.

Chang EC, Frasor J, Komm B, Katzenellenbogen BS.

Endocrinology. 2006 Oct;147(10):4831-42. Epub 2006 Jun 29.

PMID:
16809442
15.

The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.

Wang X, Yang Z, Zhang H, Ding L, Li X, Zhu C, Zheng Y, Ye Q.

Biochim Biophys Acta. 2008 Jun;1783(6):1220-8. doi: 10.1016/j.bbamcr.2008.01.026. Epub 2008 Feb 12.

16.

Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.

Herynk MH, Lewis MT, Hopp TA, Medina D, Corona-Rodriguez A, Cui Y, Beyer AR, Fuqua SA.

Oncogene. 2009 Sep 10;28(36):3177-87. doi: 10.1038/onc.2009.174. Epub 2009 Jun 29.

17.

p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.

Cancer Res. 2006 May 1;66(9):4672-80.

18.

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.

Lindberg K, Helguero LA, Omoto Y, Gustafsson JÅ, Haldosén LA.

Breast Cancer Res. 2011 Apr 14;13(2):R43. doi: 10.1186/bcr2865.

19.

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.

Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson JA.

Oncogene. 2008 Feb 7;27(7):1019-32. Epub 2007 Aug 13.

PMID:
17700529
20.

Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.

Davis VL, Shaikh F, Gallagher KM, Villegas M, Rea SL, Cline JM, Hughes CL.

Horm Cancer. 2012 Dec;3(5-6):227-39. doi: 10.1007/s12672-012-0122-x. Epub 2012 Sep 12.

PMID:
22968785

Supplemental Content

Support Center